Impetigo Overview
Impetigo is a bacterial infection that involves the superficial skinThe most common presentation is yellowish crusts on the face, arms, or leg. Less commonly there may be large blisters that affect the groin or armpits. The lesions may be painful or itchy Fever is uncommon. It is typically due to either Staphylococcus aureus or Streptococcus pyogenic disease. Risk factors include attending daycare, crowding, poor nutrition, diabetes mellitus, contact sports, and breaks in the skin such as from mosquito bites, eczema, scabies, or herpes. With contact it can spread around or between people. Diagnosis is typically based on the symptoms and appearance.
Impetigo Epidemiology Insights
Globally, impetigo affects more than 162 million children in low- to middle-income countries. The rates are highest in countries with low available resources and is especially prevalent in the region of Oceania.The tropical climate and high population in lower socioeconomic regions contribute to these high rates. Children under the age of 4 in the United Kingdom are 2.8% more likely than average to contract impetigo; this decreases to 1.6% for children up to 15 years old. As age increases, the rate of impetigo declines, but all ages are still susceptible
Click here to learn more about the Impetigo Market Landscape
The Report Covers the Impetigo Epidemiology Segmented by:
-
Total Impetigo incident cases
-
Total Impetigo prevalent cases
-
Total Impetigo treatment cases
-
Total Impetigo diagnostic cases
Impetigo Market Outlook
The Impetigo market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Impetigo market trends by analyzing the impact of current Impetigo therapies on the market, unmet needs, drivers, barriers, and demand for better technology. This segment gives a thorough detail of the Impetigo market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Impetigo market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Impetigo market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Impetigo Market
-
Novabay Pharmaceuticals
-
Union Therapeutics
-
Vyne Therapeutics
And many others
Impetigo Therapies Covered and Analyzed in the Report
-
NVC-422
-
Mupirocin
-
ATx201
And many others
Learn more about the Key Companies and Emerging Therapies in the Impetego Market
Table of Contents
-
Key Insights
-
Impetigo Introduction
-
Executive Summary of
-
Disease Background and Overview
-
Epidemiology and patient population
-
Impetigo Emerging Therapies
-
Impetigo Market Outlook
-
Market Access and Reimbursement of Therapies
-
Impetigo Market Drivers
-
Impetigo Market Barriers
-
Appendix
-
Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
Learn about the detailed offerings of the report @ Impetego Market Outlook
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
